P-glycoprotein mediated drug interactions in animals and humans with cancer
about
A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function.Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.Establishment of a cell line for assessing drugs as canine P-glycoprotein substrates: proof of principle.Advances in plant-based inhibitors of P-glycoprotein.The present and future of opioid analgesics in small animal practice.Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers.Frequency of canine nt230(del4) MDR1 mutation in prone pure breeds, their crosses and mongrels in Israel - insights from a worldwide comparative perspective.The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high-risk canine mast cell tumours to tyrosine kinase inhibitors.Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers.Adverse reaction to apomorphine in a Collie homozygous for the ABCB1-1∆ (MDR1) mutation.Herbal Bioenhancers in Veterinary PhytomedicineDrug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives
P2860
Q36962615-0AB8B6B5-C06D-40D3-B2F9-1F2BD7CDF78FQ37636632-B8646AF4-A38C-4217-829B-14AD3D80BD1CQ38721012-B64A320C-8BED-4BF4-A165-5742A80DBAC4Q38756967-D91A7957-66E0-4D1B-B229-C73FE9B54E34Q38789121-1390FAFC-539A-4E21-93F1-A72184230E86Q39125345-DCAAE07B-5A96-4D61-8C53-A0072711B16FQ46427046-EE53EB65-E51C-405C-9FD2-8F340DC25866Q48160138-336BB81A-CF1F-48C3-A853-77547E1128A7Q49310990-4702C181-9A74-483C-AD1F-EA75F131B28AQ51189166-316EDC0F-332E-427A-B3D1-A7AA481105A2Q51206987-E47E79A1-16DE-4B17-82E4-015AA637D6C1Q58576453-B2DFAC96-4117-4378-91CB-6082CC3D63CEQ59136492-29C628F4-E761-405D-8D03-8443B9C59F0D
P2860
P-glycoprotein mediated drug interactions in animals and humans with cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
P-glycoprotein mediated drug interactions in animals and humans with cancer
@ast
P-glycoprotein mediated drug interactions in animals and humans with cancer
@en
P-glycoprotein mediated drug interactions in animals and humans with cancer
@nl
type
label
P-glycoprotein mediated drug interactions in animals and humans with cancer
@ast
P-glycoprotein mediated drug interactions in animals and humans with cancer
@en
P-glycoprotein mediated drug interactions in animals and humans with cancer
@nl
prefLabel
P-glycoprotein mediated drug interactions in animals and humans with cancer
@ast
P-glycoprotein mediated drug interactions in animals and humans with cancer
@en
P-glycoprotein mediated drug interactions in animals and humans with cancer
@nl
P2860
P921
P3181
P356
P1476
P-glycoprotein mediated drug interactions in animals and humans with cancer
@en
P2093
P2860
P3181
P356
10.1111/JVIM.12525
P407
P577
2015-01-01T00:00:00Z